Product Program year 2025 Source: CMS Open Payments

Imkeldi

Drug Oncology

NDC 81927-201-01

Open in the dashboard

General payments

$1,984

84 payments

Research payments

$0

0 payments

Through program year 2025, $1,984 in general payments and $0 in research payments were reported against Imkeldi (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $1,984 84

Breakdown

Who paid General payments · program year 2025
  1. Shorla Oncology Inc. $1,984 84 payments
Top recipients General payments · program year 2025
  1. Jared Knol Medical Oncology · Grand Rapids, MI $71 4% · 1 payment
  2. Megan Sawyer Nurse Practitioner, Family · Grand Rapids, MI $71 4% · 1 payment
  3. Lilly Stallmer Physician Assistant · Grand Rapids, MI $71 4% · 1 payment
  4. Tara Webb Nurse Practitioner, Adult Health · Grand Rapids, MI $71 4% · 1 payment
  5. Aaron Zarnosky Physician Assistant · Grand Rapids, MI $71 4% · 1 payment

The top 5 of 79 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $588 30% · 26 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $305 16% · 10 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $198 10% · 10 practitioners
  4. Medical Oncology Internal Medicine $197 10% · 8 practitioners
  5. Physician Assistant $142 7% · 2 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $670 34% · 33 recipients
  2. Michigan $481 24% · 10 recipients
  3. Illinois $287 14% · 11 recipients
  4. Ohio $247 12% · 8 recipients
  5. New Jersey $75 4% · 3 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

84 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record